NEPH logo

Nephros (NEPH)

Profile

Full Name

Nephros, Inc.

Ticker Symbol

NEPH

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

September 21, 2004

Indexes

Not included

Website

http://www.nephros.com

Employees

31

Key Details

Price

$1.90(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$14.16M(-0.53% YoY)

Annual EPS

$0.01(+106.67% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.90
NEPH price is $1.90

30-Day Relative Volume

1.13
NEPH 30-day relative volume is 1.13

Price Performance

Price Most recent change

0%
NEPH {parameterFullLabel} has remained unchanged on Apr 11, 2025

Price YTD change

+29.25%
NEPH price is up +29.25% since January 1st

Price 1-year change

-5%
NEPH price is down -5% year-on-year

Price 3-year change

-57.96%
NEPH price is down -57.96% over the past 3 years

Price Range

Price All-time high

$1128.60
NEPH price is currently -99.83% below its historical high of $1128.60

Price 3-year low

$0.91
NEPH price is currently +108.79% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$20.14M
NEPH market capitalization is $20.14 million

Market cap 3-year change

-56.82%
NEPH market capitalization is down -56.82% over the past 3 years

Market cap All-time high

$106.40M
NEPH market capitalization is currently -81.07% below its historical high of $106.40 million

Market cap sector rank

27.69%
NEPH market capitalization is higher than 27.69% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.53%
NEPH shares outstanding is up +0.53% year-on-year

Shares Outstanding 3-Year Change

+2.73%
NEPH shares outstanding is up +2.73% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.24
NEPH beta is 0.24

200-day SMA

$1.71
NEPH price is currently +11.18% above its 200-day simple moving average

50-day SMA

$1.63
NEPH price is currently +16.92% above its 50-day simple moving average

RSI

59.17
NEPH 14-day relative strength index is 59.17

Volume

1.13
NEPH 30-day relative volume is 1.13

ATR

$0.11
NEPH average true range is $0.11

10-day Historical Volatility

90.10%
NEPH 10-day historical volatility is 90.10%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$14.16M
NEPH annual revenue is $14.16 million

Revenue Analysts estimate

$15.15M
NEPH annual revenue is currently -6.49% lower than the consensus analysts' forecast

Revenue 1-year change

-0.53%
NEPH annual revenue is down -0.53% year-on-year

Revenue Sector rank

32.03%
NEPH annual revenue is higher than 32.03% of companies in Healthcare sector

EPS

EPS

$0.01
NEPH annual earnings per share is $0.01

EPS Analysts estimate

$0.02
NEPH annual earnings per share is currently -50.00% lower than the consensus analysts' forecast

EPS 1-year change

+106.67%
NEPH annual earnings per share is up +106.67% year-on-year

EPS Sector rank

82.41%
NEPH annual earnings per share is higher than 82.41% of companies in Healthcare sector

Profit

Gross profit

$8.72M
NEPH annual gross profit is $8.72 million

Gross margin

61.59%
NEPH annual gross profit margin is 61.59%

Operating profit

$6000.00
NEPH annual operating income is $6000.00

Operating margin

0.04%
NEPH annual operating profit margin is 0.04%

Net income

$74.00K
NEPH annual net profit is $74.00 thousand

Net margin

0.52%
NEPH annual net profit margin is 0.52%

Expenses

Total expenses

$14.16M
NEPH annual total expenses is $14.16 million

Operating expenses

$8.72M
NEPH annual total operating expenses is $8.72 million

Cost of goods sold

$5.44M
NEPH annual cost of goods sold is $5.44 million

Selling, general & administrative expenses

$7.68M
NEPH annual SGA is $7.68 million

Depreciation and amortization

$137.00K
NEPH annual depreciation & amortization is $137.00 thousand

Interest expense

$1000.00
NEPH annual interest expense is $1000.00

Income tax

$15.00K
NEPH annual income tax is $15.00 thousand

EBIT & EBITDA

EBIT

$90.00K
NEPH annual earnings before interest & taxes is $90.00 thousand

EBITDA

$225.00K
NEPH annual EBITDA is $225.00 thousand

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$11.21M
NEPH annual total assets is $11.21 million

Non current assets

$2.91M
NEPH annual long term assets is $2.91 million

Current assets

$8.30M
NEPH annual total current assets is $8.30 million

Cash and cash equivalents

$3.76M
NEPH annual cash & cash equivalents is $3.76 million

Accounts receivable

$1.78M
NEPH annual accounts receivable is $1.78 million

Inventory

$2.62M
NEPH annual inventory is $2.62 million

Liabilities

Total liabilities

$2.63M
NEPH annual total liabilities is $2.63 million

Long term liabilities

$1.06M
NEPH annual total long term liabilities is $1.06 million

Current liabilities

$1.56M
NEPH annual total current liabilities is $1.56 million

Accounts payable

$649.00K
NEPH annual accounts payable is $649.00 thousand

Debt

Total debt

$1.41M
NEPH annual total debt is $1.41 million

Total debt 1-year change

-23.15%
NEPH annual total debt is down -23.15% year-on-year

Long term debt

$1.06M
NEPH annual long term debt is $1.06 million

Short term debt

$348.00K
NEPH annual short term debt is $348.00 thousand

Equity & Capital

Shareholders equity

$8.59M
NEPH annual stockholders equity is $8.59 million

Book value

$8.59M
NEPH annual book value is $8.59 million

Retained earnings

-$144.33M
NEPH annual retained earnings is -$144.33 million

Working capital

$6.74M
NEPH annual working capital is $6.74 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$492.00K
NEPH annual cash flow from operations is -$492.00 thousand

Cash from operations 1-year change

-159.49%
NEPH annual cash flow from operations is down -159.49% year-on-year

Cash from investing

-$50.00K
NEPH annual cash flow from investing activities is -$50.00 thousand

Cash from investing 1-year change

+33.33%
NEPH annual cash flow from investing activities is up +33.33% year-on-year

Cash from financing

-$5000.00
NEPH annual cash flow from financing activities is -$5000.00

Cash from financing 1-year change

+93.67%
NEPH annual cash flow from financing activities is up +93.67% year-on-year

CAPEX

CAPEX

$55.00K
NEPH annual capital expenditures is $55.00 thousand

CAPEX 1-year change

-26.67%
NEPH annual capital expenditures is down -26.67% year-on-year

Free Cash Flow

Free cash flow

-$547.00K
NEPH annual free cash flow is -$547.00 thousand

Free cash flow 1-year change

-172.74%
NEPH annual free cash flow is down -172.74% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

61.59%
NEPH annual gross profit margin is 61.59%

Operating margin

0.04%
NEPH annual operating profit margin is 0.04%

Net margin

0.52%
NEPH annual net profit margin is 0.52%

ROA & ROE

ROA

0.64%
NEPH annual return on assets is 0.64%

ROE

0.87%
NEPH annual return on equity is 0.87%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
NEPH price to earnings ratio value is unknown

PE ratio Sector rank

-
NEPH price to earnings ratio is unknown

PB Ratio

PB ratio

2.35
NEPH price to book ratio is 2.35

PB ratio Sector rank

67.11%
NEPH price to book ratio is higher than 67.11% of companies in Healthcare sector

PS Ratio

PS ratio

1.42
NEPH price to sales ratio is 1.42

PS ratio Sector rank

35.13%
NEPH price to sales ratio is higher than 35.13% of companies in Healthcare sector

Enterprise value

Enterprise value

$17.79M
NEPH enterprise value is $17.79 million

Enterprise value Sector rank

31.21%
NEPH enterprise value is higher than 31.21% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

78.38
NEPH EV/EBITDA is 78.38

EV/EBITDA Sector rank

98.44%
NEPH EV/EBITDA is higher than 98.44% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

5.31
NEPH annual current ratio is 5.31

Quick ratio

3.64
NEPH annual quick ratio is 3.64

Leverage

Debt to equity

0.00
NEPH annual debt to equity ratio is 0.00

Interest coverage ratio

90.00
NEPH annual interest coverage ratio is 90.00

Risk & Stability

Piotroski F-Score

5
NEPH piotroski f-score is 5

Altman Z-Score

-11.41
NEPH altman z-score is -11.41

Analyst ratings

Recent major analysts updates

Nov 12, 24 Benchmark
Speculative Buy
May 15, 24 Benchmark
Speculative Buy
Mar 8, 24 Benchmark
Speculative Buy
Jan 26, 21 B. Riley Securities
Buy
Jan 26, 21 B. Riley FBR
Buy
Nov 25, 20 Maxim Group
Buy
Nov 25, 20 Benchmark
Speculative Buy
Oct 24, 19 Benchmark
Speculative Buy
Oct 4, 19 Maxim Group
Buy

Institutional Ownership

Similar stocks

CMMB logo
Chemomab Therapeutics (CMMB)
RVP logo
Retractable Technologies (RVP)
FNCH logo
Finch Therapeutics (FNCH)
OVID logo
Ovid Therapeutics (OVID)
BFRG logo
Bullfrog AI Holdings (BFRG)
IPA logo
ImmunoPrecise Antibodies (IPA)
PULM logo
Pulmatrix (PULM)
CalciMedica (CALC)
CYTH logo
Cyclo Therapeutics (CYTH)
  • What is the ticker symbol for Nephros?
  • Does Nephros pay dividends?
  • What sector is Nephros in?
  • What industry is Nephros in?
  • What country is Nephros based in?
  • When did Nephros go public?
  • Is Nephros in the S&P 500?
  • Is Nephros in the NASDAQ 100?
  • Is Nephros in the Dow Jones?
  • When was Nephros's last earnings report?
  • When does Nephros report earnings?
  • Should I buy Nephros stock now?

What is the ticker symbol for Nephros?

The ticker symbol for Nephros is NASDAQ:NEPH

Does Nephros pay dividends?

No, Nephros does not pay dividends

What sector is Nephros in?

Nephros is in the Healthcare sector

What industry is Nephros in?

Nephros is in the Medical Instruments & Supplies industry

What country is Nephros based in?

Nephros is headquartered in United States

When did Nephros go public?

Nephros's initial public offering (IPO) was on September 21, 2004

Is Nephros in the S&P 500?

No, Nephros is not included in the S&P 500 index

Is Nephros in the NASDAQ 100?

No, Nephros is not included in the NASDAQ 100 index

Is Nephros in the Dow Jones?

No, Nephros is not included in the Dow Jones index

When was Nephros's last earnings report?

Nephros's most recent earnings report was on Mar 6, 2025

When does Nephros report earnings?

The next expected earnings date for Nephros is May 9, 2025

Should I buy Nephros stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page